-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WzSlTdkyTk5U69eqkYZz4hSsV6B/kAYEexgUNm+MtyrS18883YAfrM4RpRisxitJ Gylek7Fu7J+Cf/ppVBVDfQ== 0000920148-96-000029.txt : 19961205 0000920148-96-000029.hdr.sgml : 19961205 ACCESSION NUMBER: 0000920148-96-000029 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19961121 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 19961204 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 96675823 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 8002227566 MAIL ADDRESS: STREET 1: NATIONAL HEALTH LABORATORIES HOLDINGS IN STREET 2: 4225 EXECUTIVE SQUARE, SUITE 800 CITY: LAJOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 4, 1996 ---------------- (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 1-11353 13-3757370 -------- ------- ---------- (State or other (Commission (IRS Employer jurisdiction or File Number) Identification organization) Number) 358 South Main Street, Burlington, North Carolina 27215 -------------------------------------------------------- (Address of principal executive offices) 910-229-1127 ------------ (Registrant's telephone number, including area code) Item 5. Other Events On December 4, 1996, the Company issued a press release announcing the resignation of David C. Weavil, Executive Vice President and Chief Operating Officer and that Ronald B. Sturgill, Executive Vice President, is assuming responsibilities as Chief Operating Officer until a successor is named. The press release is attached as an exhibit hereto and the text thereof is incorporated in its entirety herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits 20 Press release of the Registrant dated December 4, 1996. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By: /s/ BRADFORD T. SMITH --------------------------------------------- Bradford T. Smith Executive Vice President, General Counsel and Secretary Date: December 4, 1996 EX-20 2 Exhibit 20 FOR IMMEDIATE RELEASE Contact: Pamela Sherry Telephone: (910) 584-5171 Ext. 6768 LABORATORY CORPORATION OF AMERICA ANNOUNCES RESIGNATION OF DAVID C. WEAVIL, EVP AND COO Burlington, NC, December 4, 1996 -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) today announced the resignation of David C. Weavil, Executive Vice President and Chief Operating Officer, effective immediately. Mr. Weavil's resignation came as a result of LabCorp's recently announced government settlement, and resolves all issues related to 1993- initiated federal investigations of prior billing practices for LabCorp's predecessor companies. These investigations, which were part of a broad-based inquiry into industry-wide billing practices, have resulted in settlements with a number of other clinical laboratories to date and are expected to result in additional settlements in the near future. Ronald B. Sturgill, Executive Vice President, is assuming responsibilities as Chief Operating Officer until a successor is named. Mr. Sturgill, whose current responsibilities include Human Resources and the South Atlantic Operating Division, is a 25-year veteran of the Company and the clinical laboratory industry. Laboratory Corporation of America Holdings (LabCorp) is a national clinical laboratory organization with estimated annualized revenues of $1.6 billion. The Company operates primary testing facilities nationally, offering more than 1,700 different clinical assays, from routine blood analysis to more sophisticated technologies. LabCorp performs diagnostic tests for physicians, managed care organizations, hospitals, clinics, long-term care facilities, industrial companies and other clinical laboratories. ### -----END PRIVACY-ENHANCED MESSAGE-----